CAS: 1216744-19-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK 4112 REF: IN-DA009CI5CAS: 1216744-19-2 | % | To inquire | Tue 10 Dec 24 |
 | GSK4112 REF: TM-T5045CAS: 1216744-19-2 | 99.63% | 35.00 €~421.00 € | Mon 16 Dec 24 |
 | GSK4112 REF: 3D-RYB74419CAS: 1216744-19-2 | Min. 95% | To inquire | Tue 21 Jan 25 |
 | GSK 4112 REF: TR-G797700CAS: 1216744-19-2 | - - - | - - - | Discontinued product |
Ref: IN-DA009CI5
| 1g | To inquire | ||
| 10mg | 58.00 € | ||
| 50mg | 142.00 € | ||
| 100mg | 178.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
GSK4112
CAS:1216744-19-2
GSK4112 (SR6452) is a Rev-erbα agonist with EC50 of 0.4 μM, also is a small …
Formula:
C18H21ClN2O4S
Purity:
99.63%
Color and Shape:
Solid
Molecular weight:
396.89
Ref: TM-T5045
| 10mg | 49.00 € | ||
| 25mg | 93.00 € | ||
| 50mg | 169.00 € | ||
| 100mg | 293.00 € | ||
| 200mg | 421.00 € | ||
| 1mL*10mM (DMSO) | 35.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
GSK4112
CAS:1216744-19-2
GSK4112 is a novel, orally bioavailable compound that is being developed for the treatment of …
Formula:
C18H21ClN2O4S
Purity:
Min. 95%
Molecular weight:
396.89 g/mol
Ref: 3D-RYB74419
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
GSK 4112
CAS:1216744-19-2
Applications GSK 4112 is a synthetic ligand for REV-ERBα, a member of the nuclear receptor …
Formula:
C18H21ClN2O4S
Color and Shape:
Pale Yellow to Light Yellow Solid
Molecular weight:
396.89
Ref: TR-G797700
| 5mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
